Humacyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	19.49	44.94	80.45	149.77	217.5	39.93
Short-Term Investments	-	-	-	2.11	8	-
Cash & Short-Term Investments	19.49	44.94	80.45	151.88	225.5	39.93
Cash Growth	-5.27%	-44.14%	-47.03%	-32.65%	464.76%	-57.39%
Receivables	1.08	-	-	0.03	0.18	0.11
Prepaid Expenses	2.22	2.78	2.69	2.3	3.66	1.41
Restricted Cash	0.14	0.14	0.14	-	-	-
Total Current Assets	41.35	47.86	83.28	154.21	229.34	41.45
Property, Plant & Equipment	49.28	38.55	44.1	49.41	57.19	65.24
Other Long-Term Assets	0.88	51.46	0.84	0.68	-	-
Total Assets	91.51	137.87	128.22	204.3	286.53	106.69
Accounts Payable	9.58	4.49	6.49	1.6	2.09	2.27
Accrued Expenses	10.26	11.42	9.34	7.11	6.76	4.59
Current Portion of Long-Term Debt	3.07	0.9	-	8.57	-	2.45
Current Portion of Leases	2.67	3.02	2.56	2.31	2.03	1.77
Other Current Liabilities	-	0.12	0.05	-	0.17	0.15
Total Current Liabilities	25.58	19.95	18.44	19.58	11.05	11.23
Long-Term Debt	18.07	63.35	38.6	20.34	27.36	0.82
Long-Term Leases	27.16	14.09	16.89	19.45	21.79	23.82
Other Long-Term Liabilities	25.45	93.14	40.74	28.01	104.16	0.14
Total Liabilities	96.26	190.54	114.68	87.37	164.36	36.02
Common Stock	0.02	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	697.28	633.33	550.85	543.46	536.74	37.78
Retained Earnings	-702.04	-686.02	-537.31	-426.54	-414.57	-388.1
Total Common Equity	-4.75	-52.67	13.55	116.93	122.17	-350.32
Shareholders' Equity	-4.75	-52.67	13.55	116.93	122.17	70.67
Total Liabilities & Equity	91.51	137.87	128.22	204.3	286.53	106.69
Total Debt	50.97	81.37	58.05	50.67	51.18	28.86
Net Cash (Debt)	-31.48	-36.43	22.4	101.21	174.32	11.07
Net Cash Growth	-	-	-77.87%	-41.94%	1475.03%	-83.36%
Net Cash Per Share	-0.22	-0.31	0.22	0.98	4.36	1.92
Filing Date Shares Outstanding	187.27	155.12	119.08	103.33	103	22.17
Total Common Shares Outstanding	158.84	130.03	103.67	103.23	103	22.17
Working Capital	15.77	27.91	64.84	134.63	218.29	30.22
Book Value Per Share	-0.03	-0.41	0.13	1.13	1.19	-15.80
Tangible Book Value	-4.75	-52.67	13.55	116.93	122.17	-350.32
Tangible Book Value Per Share	-0.03	-0.41	0.13	1.13	1.19	-15.80
Machinery	30.93	30.23	29.59	28.98	28.78	28.55
Construction In Progress	-	-	-	0.68	-	-
Leasehold Improvements	27.97	27.9	27.84	26.36	26.36	26.36

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q